Cargando…

Exosomal MicroRNAs as Potential Biomarkers of Hepatic Injury and Kidney Disease in Glycogen Storage Disease Type Ia Patients

Glycogen storage disease type Ia (GSDIa) is an inherited metabolic disorder caused by mutations in the enzyme glucose-6-phosphatase-α (G6Pase-α). Affected individuals develop renal and liver complications, including the development of hepatocellular adenoma/carcinoma and kidney failure. The purpose...

Descripción completa

Detalles Bibliográficos
Autores principales:	Resaz, Roberta, Cangelosi, Davide, Segalerba, Daniela, Morini, Martina, Uva, Paolo, Bosco, Maria Carla, Banderali, Giuseppe, Estrella, Ana, Wanner, Corbinian, Weinstein, David A., Sechi, Annalisa, Paci, Sabrina, Melis, Daniela, Di Rocco, Maja, Lee, Young Mok, Eva, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745197/ https://www.ncbi.nlm.nih.gov/pubmed/35008754 http://dx.doi.org/10.3390/ijms23010328

Ejemplares similares

Circulating exosomal microRNAs as potential biomarkers of hepatic injury and inflammation in a murine model of glycogen storage disease type 1a
por: Resaz, Roberta, et al.
Publicado: (2020)

Characterization of high- and low-risk hepatocellular adenomas by magnetic resonance imaging in an animal model of glycogen storage disease type 1A
por: Resaz, Roberta, et al.
Publicado: (2019)

Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia
por: Rossi, Alessandro, et al.
Publicado: (2023)

Immunohistochemical analysis of PDK1, PHD3 and HIF-1α expression defines the hypoxic status of neuroblastoma tumors
por: Ognibene, Marzia, et al.
Publicado: (2017)

Glycogen Storage Disease Type Ia in Canines: A Model for Human Metabolic and Genetic Liver Disease
por: Specht, Andrew, et al.
Publicado: (2011)

Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation
por: Melis, Daniela, et al.
Publicado: (2015)

Plasma-Derived Exosome Proteins as Novel Diagnostic and Prognostic Biomarkers in Neuroblastoma Patients
por: Morini, Martina, et al.
Publicado: (2023)

Geneotype and phenotype in 20 patients with glycogen storage disease type Ia
por: Liang, Cuili, et al.
Publicado: (2013)

Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia
por: Kruger, Eliza, et al.
Publicado: (2023)

Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI
por: Wilson, Lane H., et al.
Publicado: (2019)

The SGLT2-inhibitor dapagliflozin improves neutropenia and neutrophil dysfunction in a mouse model of the inherited metabolic disorder GSDIb
por: Resaz, Roberta, et al.
Publicado: (2021)

A Mouse Model of Glycogen Storage Disease Type IX-Beta: A Role for Phkb in Glycogenolysis
por: Arends, Charles J., et al.
Publicado: (2022)

Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control
por: Peeks, Fabian, et al.
Publicado: (2017)

Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia
por: den Hollander, N. C., et al.
Publicado: (2007)

Continuous glucose monitoring in the treatment of obesity in patients with glycogen storage disease type Ia
por: Korljan Jelaska, Betty, et al.
Publicado: (2013)

Glycogen storage disease type Ia: Adult presentation with microcytic anemia and liver adenomas
por: Moest, Wouter, et al.
Publicado: (2018)

Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa)
por: Farah, Benjamin L., et al.
Publicado: (2017)

Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs
por: Derks, Terry G. J., et al.
Publicado: (2021)

Very early-onset inflammatory bowel disease: Novel description in glycogen storage disease type Ia
por: Hannah, William B., et al.
Publicado: (2022)

Diabetes mellitus in a patient with glycogen storage disease type Ia: a case report
por: Cohn, Aviva, et al.
Publicado: (2017)

Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia
por: Kang, Hye-Ri, et al.
Publicado: (2019)

A Novel Mutation in a Newborn Baby Leading to Glycogen Storage Disease Type Ia
por: Dorum, S, et al.
Publicado: (2018)

Papillary renal cell carcinoma in two young adults with glycogen storage disease type Ia
por: Perry, Ariane, et al.
Publicado: (2020)

Development of hepatocellular adenomas and carcinomas in mice with liver-specific G6Pase-α deficiency
por: Resaz, Roberta, et al.
Publicado: (2014)

Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia
por: Cho, Jun-Ho, et al.
Publicado: (2017)

Case Report: Glycogen Storage Disease Type Ia in a Chinese Child Treated With Growth Hormone
por: Wu, Shimin, et al.
Publicado: (2022)

Double filtration plasmapheresis for pregnancy with hyperlipidemia in glycogen storage disease type Ia: A case report
por: Wang, Jie, et al.
Publicado: (2022)

Successful Treatment of Refractory Anemia in a Patient With Glycogen Storage Disease Type Ia Undergoing Hemodialysis
por: Sato, Hirotaka, et al.
Publicado: (2022)

A patient with glycogen storage disease type IA combined with hepatic adenoma: A case report
por: Yin, Maohui, et al.
Publicado: (2022)

Development of hepatocellular adenomas in a patient with glycogen storage disease Ia treated with growth hormone therapy
por: Jackson, David G., et al.
Publicado: (2023)

Minimal hepatic glucose-6-phosphatase-α activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia
por: Lee, Young Mok, et al.
Publicado: (2015)

A case report of acute pancreatitis with glycogen storage disease type IA in an adult patient and review of the literature
por: Ai, Jiaoyu, et al.
Publicado: (2020)

Impaired Very‐Low‐Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia
por: Hoogerland, Joanne A., et al.
Publicado: (2021)

A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets
por: Rossi, Alessandro, et al.
Publicado: (2022)

Glycogen storage disease type Ia misdiagnosed as multiple acyl-coenzyme A dehydrogenase deficiency by mass spectrometry
por: Du, Juan, et al.
Publicado: (2022)

From Puppies to adults: In vivo editing of hepatocytes in a canine model of glycogen storage disease type Ia
por: Chandler, Randy J.
Publicado: (2023)

Extracellular vesicle‐derived microRNAs as potential biomarkers in oligoarticular juvenile idiopathic arthritis patients: methodological challenges and new perspectives
por: Raggi, Federica, et al.
Publicado: (2022)

Pituitary hypoplasia and growth hormone deficiency in a woman with glycogen storage disease type Ia: a case report
por: Dagdelen, Selcuk, et al.
Publicado: (2008)

Three novel mutations of the G6PC gene identified in Chinese patients with glycogen storage disease type Ia
por: Zheng, Bi-Xia, et al.
Publicado: (2014)

A patient with glycogen storage disease type Ia combined with chronic hepatitis B infection: a case report
por: Wang, Wenying, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t901qvdj7j69sr6qerhaloh04o